Health Canada has approved a new Respiratory Syncytial Virus (RSV) vaccine geared toward protecting two of the groups most severely affected by the virus: newborns, who would receive antibodies through maternal immunization, and Canadians over 60.
Health Canada has approved a new Respiratory Syncytial Virus (RSV) vaccine geared toward protecting two of the groups most severely affected by the virus: newborns, who would receive antibodies through maternal immunization, and Canadians over 60.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.